Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region
FLYAK. 2018. NATURE MICROBIOLOGY 3, 670-677.
RESOURCES
Where research scientists come to find up to date resources on antibody discovery against challenging membrane protein targets.
Menu
Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins
MOUSA. 2018. PLOS PATHOGENS 14(2), e1006837.
High-throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers
SULLIVAN, ET AL. 2017. J VIROL 91(22), E00862-17.
Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis
GOPAL, ET AL. 2017. PLOS PATHOGENS 13(12), E1006735.
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability
ZHAO ET AL. 2017. CELL 169, 891-904.
Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
HOWELL ET AL. 2017. CELL REP 19(2), 413-424.
Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance
BAILEY ET AL. 2017. JCI INSIGHT 2(9), E92872.
A Biologically-validated HCV E1E2 Heterodimer Structural Model
CASTELLI ET AL. 2017. SCI REP 7, 214-227.
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
NIVARTHI ET AL. 2017. J VIROL 91(5), E02041-02056.
